Urologix makes interim chief Greg Fluet permanent CEO
This article was originally published in Clinica
Executive Summary
Greg Fluet, who has been acting as Urologix's interim CEO since November, has been appointed to the role on a permanent basis. Mr Fluet, who has also been elected to the firm's board of directors, joined Urologix in July 2008 as chief operating officer and executive vice-president. He has been filling in as CEO since previous incumbent Stryker Warren retired last year (www.clinica.co.uk, 10 December 2012). Minneapolis, Minnesota-based Urologix, which is developing minimally-invasive devices to treat benign prostatic hyperplasia, is due to announce its second quarter results on 5 February.